Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.
作者信息
Singhera M, Huddart R
机构信息
Department of Urology, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Surrey, UK.
出版信息
Br J Cancer. 2013 Oct 29;109(9):2502-3. doi: 10.1038/bjc.2013.566. Epub 2013 Sep 17.
Abstract
摘要
相似文献
1
Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.关于“化疗治疗的睾丸生殖细胞肿瘤幸存者的代谢综合征患病率及心血管疾病风险”的评论
Br J Cancer. 2013 Oct 29;109(9):2502-3. doi: 10.1038/bjc.2013.566. Epub 2013 Sep 17.
2
Reply: 'Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.回复：“关于化疗治疗的睾丸生殖细胞肿瘤幸存者中代谢综合征的患病率和心血管疾病风险的评论”
Br J Cancer. 2013 Oct 29;109(9):2503-4. doi: 10.1038/bjc.2013.567. Epub 2013 Sep 17.
3
Re: Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.关于：化疗治疗的睾丸生殖细胞肿瘤幸存者中代谢综合征的患病率及心血管疾病风险
J Urol. 2013 Nov;190(5):1768. doi: 10.1016/j.juro.2013.07.096. Epub 2013 Aug 2.
4
Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.化疗治疗的睾丸生殖细胞肿瘤幸存者中代谢综合征和心血管疾病风险的流行率。
Br J Cancer. 2013 Jul 9;109(1):60-7. doi: 10.1038/bjc.2013.226. Epub 2013 May 9.
5
The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy.单纯手术与手术联合铂类化疗治疗的生殖细胞肿瘤幸存者的低促性腺激素血症对生活质量的影响。
Support Care Cancer. 2020 Jul;28(7):3165-3170. doi: 10.1007/s00520-019-05117-0. Epub 2019 Nov 9.
6
Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.睾丸癌患者的性腺功能减退与心血管疾病和代谢综合征的危险因素相关。
Andrology. 2017 Jul;5(4):711-717. doi: 10.1111/andr.12354. Epub 2017 May 23.
7
Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer.局部睾丸癌的辅助化疗及复发后的随访
Future Oncol. 2017 May;13(11):947-950. doi: 10.2217/fon-2017-0047.
8
Testicular germ cell tumours - still many challenges.睾丸生殖细胞肿瘤——仍面临诸多挑战。
Acta Oncol. 2012 Feb;51(2):147-50. doi: 10.3109/0284186X.2011.653441.
9
Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.I期生殖细胞肿瘤患者辅助化疗相关的中长期并发症。
Curr Opin Urol. 2018 Sep;28(5):485-490. doi: 10.1097/MOU.0000000000000527.
10
Testicular germ cell tumors. An update on clinical pathologic correlation.睾丸生殖细胞肿瘤。临床病理相关性的最新进展。
Acta Pathol Jpn. 1991 Feb;41(2):83-93.
引用本文的文献
1
Reply: 'Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.回复：“关于化疗治疗的睾丸生殖细胞肿瘤幸存者中代谢综合征的患病率和心血管疾病风险的评论”
Br J Cancer. 2013 Oct 29;109(9):2503-4. doi: 10.1038/bjc.2013.567. Epub 2013 Sep 17.
本文引用的文献
1
Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.化疗治疗的睾丸生殖细胞肿瘤幸存者中代谢综合征和心血管疾病风险的流行率。
Br J Cancer. 2013 Jul 9;109(1):60-7. doi: 10.1038/bjc.2013.226. Epub 2013 May 9.
2
Early development of the metabolic syndrome after chemotherapy for testicular cancer.化疗治疗睾丸癌后代谢综合征的早期发展。
Ann Oncol. 2013 Mar;24(3):749-55. doi: 10.1093/annonc/mds527. Epub 2012 Nov 6.
3
Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?一级预防中的心血管风险评估系统：它们有差异吗？它们有作用吗？我们能预见未来吗？
Circulation. 2010 Jul 20;122(3):300-10. doi: 10.1161/CIRCULATIONAHA.109.852756.
4
Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool.谁超过了ATP-III风险阈值？对ATP-III风险评估工具中不同年龄和风险因素水平的影响进行系统审查。
Prev Med. 2008 Dec;47(6):619-23. doi: 10.1016/j.ypmed.2008.07.012. Epub 2008 Jul 29.
5
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse.睾丸癌随访的循证实用指南：优化复发检测
Br J Cancer. 2008 Jun 17;98(12):1894-902. doi: 10.1038/sj.bjc.6604280.
6
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).欧洲临床实践中心血管疾病预防指南：全文。欧洲心脏病学会及其他学会关于临床实践中心血管疾病预防的第四联合工作组（由九个学会的代表及特邀专家组成）。
Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. doi: 10.1097/01.hjr.0000277983.23934.c9.
7
Framingham risk score and prediction of coronary heart disease death in young men.弗雷明汉风险评分与青年男性冠心病死亡预测
Am Heart J. 2007 Jul;154(1):80-6. doi: 10.1016/j.ahj.2007.03.042.
8
Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies.代谢综合征与心血管事件及死亡风险：纵向研究的系统评价与荟萃分析
J Am Coll Cardiol. 2007 Jan 30;49(4):403-14. doi: 10.1016/j.jacc.2006.09.032. Epub 2007 Jan 12.
9
Components of the metabolic syndrome in long-term survivors of testicular cancer.睾丸癌长期幸存者的代谢综合征组成部分。
Ann Oncol. 2007 Feb;18(2):241-8. doi: 10.1093/annonc/mdl372. Epub 2006 Oct 23.
10
Fertility, gonadal and sexual function in survivors of testicular cancer.睾丸癌幸存者的生育能力、性腺及性功能
Br J Cancer. 2005 Jul 25;93(2):200-7. doi: 10.1038/sj.bjc.6602677.
Zotero 插件